Close Menu

Rockefeller University

Criteria Not Yet Met

An international committee finds genome editing is not yet ready to be used on human embryos.

Labs are finding cheaper, higher-throughput ways to determine the inflection points in gene expression within a particular cell.

A pre-flare-up transcriptional profile in the blood led the team to a group of "pre-inflammation mesenchymal," or PRIME, cells in rheumatoid arthritis.

At Scientific American, a trio calls on community leaders, scientists, and others to prevent increased racial and economic disparities in science due to pandemic-related school closures.

The charity also announced a partnership with Sage Bionetworks to establish an online repository for biomarker data generated by grant recipients.

The team believes that the project will find genetic factors involved in the development of severe COVID-19 in patients that lack risk factors. 

Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.

Using 350 human genomes from different populations, the two centers plan to develop a multi-genome reference sequence that is as complete as possible.

For a Breakthrough

Winners of this year's Breakthrough Prize in the life sciences include researchers who studied neurodegenerative disorders and protein folding.

Illumina is contributing reagents for 100 genomes worth of short-read sequence data to help scientists generate 100 new high-quality reference genomes.

Pages

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.